Scinovex
articleTop 1% cited

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression

Metabolism · 2009 · Vol. 59(2) · pp. 285–292
Hao ZhangJing WeiRong XueJindan WuWei ZhaoZizheng WangShukui WangZheng-Xian ZhouDanqing SongYueming WangHuai-Ning PanWeijia KongJian‐Dong Jiang
Berberine and alkaloids researchNatural Antidiabetic Agents StudiesDrug Transport and Resistance MechanismsMetforminInsulinInternal medicineInsulin receptorBerberineEndocrinologyRosiglitazoneMedicineType 2 Diabetes MellitusDiabetes mellitus

MeSH terms

RosiglitazoneAgedBerberineBlood GlucoseCell LineDiabetes Mellitus, Type 2FemaleHumansHyperglycemiaHypoglycemic AgentsInsulinLiver DiseasesMaleMetforminMiddle Aged
Citations
429
FWCI
15.56
field-weighted impact
References
46
Percentile
99%
vs. same field & year
Citations per year
Cited by
Current knowledge and pharmacological profile of berberine: An update
European Journal of Pharmacology · 2015 · 519 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression · Scinovex